1. Comparison of the effects of bepridil and aprindine for the prevention of atrial fibrillation after cardiac and aortic surgery: A prospective randomized study
- Author
-
Mahito Ozawa, MD, Takashi Komatsu, MD, Yoshihiro Sato, MD, Fusanori Kunugita, MD, Hideaki Tachibana, MD, Atsushi Tashiro, MD, Hitoshi Okabayashi, MD, and Motoyuki Nakamura, MD,PhD
- Subjects
Atrial fibrillation ,Cardiovascular surgery ,Bepridil ,Aprindine ,Prevention ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Background: Approximately one-third of the patients undergoing cardiovascular surgery reportedly experience paroxysmal atrial fibrillation (AF) during the postoperative period. However, the usefulness of antiarrhythmic drugs for preventing postoperative AF recurrence in the Japanese population has not been extensively studied. Methods: From a total of 118 patients who developed postoperative paroxysmal AF between April 2009 and March 2011, 72 patients (45 men, mean age 68±8 years) requiring treatment for postoperative AF due to symptoms lasting ≥30 min were enrolled to prospectively investigate the efficacy of oral bepridil (100 mg/day, n=37) or aprindine (40 mg/day, n=35). Result: The AF recurrence-free survival rates at 1, 3, 7, and 14 days were 100%, 94%, 57%, and 49%, respectively, in the aprindine group, and 100%, 97%, 86%, and 76%, respectively, in the bepridil group (P=0.028, aprindine vs. bepridil). Conclusion: Bepridil, at a fixed dose of 100 mg/day, was considered to be more effective than a routine dose of aprindine for the prevention of postoperative AF recurrence.
- Published
- 2015
- Full Text
- View/download PDF